A homogenous frameshift mutation in LRAT causes retinitis punctata albescens

Autor: Karin W. Littink, Frans C. C. Riemslag, Linda Visser, Mary J. van Schooneveld, Anneke I. den Hollander, Maria M. van Genderen, L. Ingeborgh van den Born, Jan E.E. Keunen, Bjorn Bakker, Marijke N. Zonneveld, Frans P.M. Cremers
Přispěvatelé: Netherlands Institute for Neuroscience (NIN), AII - Amsterdam institute for Infection and Immunity, Ophthalmology
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Adult
Candidate gene
medicine.medical_specialty
Genetics and epigenetic pathways of disease [NCMLS 6]
Adolescent
genetic structures
DNA Mutational Analysis
Visual Acuity
Fundus (eye)
Compound heterozygosity
Polymerase Chain Reaction
Polymorphism
Single Nucleotide

Retina
Frameshift mutation
Young Adult
Cone dystrophy
Retinal Diseases
Ophthalmology
Evaluation of complex medical interventions Genomic disorders and inherited multi-system disorders [NCEBP 2]
medicine
Electroretinography
Humans
Fluorescein Angiography
Child
Frameshift Mutation
Aged
Genetics
medicine.diagnostic_test
business.industry
Homozygote
Fundus photography
Middle Aged
medicine.disease
Disease gene identification
Alcohol Oxidoreductases
Visual Field Tests
Visual Fields
business
Genetics and epigenetic pathways of disease Genomic disorders and inherited multi-system disorders [NCMLS 6]
Carrier Proteins
Acyltransferases
Tomography
Optical Coherence

Retinopathy
Zdroj: Ophthalmology, 119, 1899-1906. Elsevier B.V.
Ophthalmology, 119(9), 1899-1906. Elsevier Inc.
Ophthalmology, 119, 9, pp. 1899-906
Ophthalmology, 119, 1899-906
ISSN: 0161-6420
Popis: Purpose: To determine the genetic defect and to describe the clinical characteristics in patients with retinitis punctata albescens (RPA) and fundus albipunctatus (FAP). Design: Case series/observational study. Participants: We included 13 patients affected by RPA or FAP. Methods: Thirteen patients were collected from 8 families with a retinal dystrophy characterized by tiny, yellow-white dots on funduscopy, typical for FAP or RPA. All patients underwent full ophthalmologic examinations, including visual field assessment. Fundus photography, and electroretinography were performed in 12 patients, and optical coherence tomography and fundus autofluorescence were performed in 4 patients. DNA samples of all patients were screened for mutations in RLBP1 and for mutations in RDH5 in patients who did not carry mutations in RLBP1. DNA samples of 2 sibling pairs of nonconsanguineous families who carried mutations neither in RLBP1 nor in RDH5 were analyzed by genome-wide homozygosity mapping. Sequence analysis was performed of LRAT, a candidate gene in a shared homozygous region. Main Outcome Measures: We assessed DNA sequence variants, best-corrected visual acuity, fundus appearance, visual field measurements, electroretinogram responses, optical coherence tomography, and fundus autofluorescence. Results: A homozygous frameshift mutation was identified in LRAT in 4 patients with RPA. Mutations in RLBP1 were identified in 7 patients with RPA and in 1 patient with FAP and cone dystrophy. One patient had compound heterozygous mutations in RDH5 and suffered from FAP with mild maculopathy. Conclusions: A genetic defect was identified in LRAT as a novel cause of RPA. LRAT is therefore the fourth gene involved in the visual cycle that may cause a white-dot retinopathy. We also revealed that mutations in RLBP1 may lead to FAP with cone dystrophy. Financial Disclosure(s): The authors have no proprietary or commercial interest in any materials discussed in this article. Ophthalmology 2012; 119: 1899-1906 (C) 2012 by the American Academy of Ophthalmology
Databáze: OpenAIRE